Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Septin-1 (SEPTIN1) is a cytoskeletal, filament-forming GTPase that is a member of the septin family, which is widely conserved among eukaryotes except plants. Septins form homo- and heterooligomeric complexes that assemble into filaments, rings, and higher-order structures crucial for various cellular processes, including cytokinesis, membrane compartmentalization, and scaffold formation for protein localization. Septin-1 participates in cell division, cellular morphology maintenance, and possibly in neuronal integrity by its association with tau protein and neurofibrillary tangle formation, implicating a disease role in Alzheimer's disease. SEPTIN1 has been identified as a potential cancer antigen in breast cancer, but it is not currently a routine established therapeutic target nor associated with specific drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Septin-1 (SEPTIN1).